
United States · Research startup
VitaPath Genetics is a biotechnology and molecular diagnostics company based in Foster City, California, founded in 2009.
Funding reportedLast round: Series C
Follow VitaPath Genetics and see its new rounds in your feed.Start following
VitaPath Genetics is a biotechnology and molecular diagnostics company based in Foster City, California, founded in 2009.
The company specializes in genomic-based tests that identify genetic variants associated with vitamin-responsive conditions. These tests assist physicians in determining whether targeted vitamin therapy can help reduce disease risk. VitaPath Genetics offers DNA-based diagnostic testing, with an initial focus on a genetic test for spina bifida risk in expectant mothers. The company provides genetic and prenatal testing services, developing a range of DNA tests aimed at lowering the risk of serious diseases. Their mission includes studying the "Vitanome," which relates to genetic information that influences vitamin metabolism and associated pathways.
Funding, as reported
From the SEC filings it signed: 4 on the team.
On the board, as filediCatherine M. BurzikMichael BorrusRowan Chapman
What they build
Known for
biotechnology researchbiotechnologylife sciences
Add your raise, your deck and your story, and put VitaPath Genetics in front of investors. Or tell us what we have wrong.